Medpace Inc (MEDP)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Medpace Inc (MEDP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013926
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medpace Inc (Medpace), a subsidiary of Medpace Holdings Inc is a contract research organization that develops research based drug and medical device. The organization’s services comprise medical affairs, regulatory affairs and medical writing, clinical monitoring, clinical trial management, biostatistics and data sciences, drug safety and pharmacovigilance, quality assurance, core labs and technology services. It offers research in the therapeutic areas of metabolism, cardiology, oncology, infectious disease, nephrology, regenerative medicine, and gastrointestinal disorders. The organization operates in Australia, the US and other European, Asian, the Middle East, African, and the American countries. Medpace is headquartered in Cincinnati, Ohio, the US.

Medpace Inc (MEDP) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medpace Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medpace Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medpace Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medpace Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medpace Inc, Medical Devices Deals, 2011 to YTD 2017 9
Medpace Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medpace Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Cinven Acquires Medpace from CCMP Capital Advisors for USD915 Million 11
CCMP Capital Advisors Completes Acquisition Of 80% Interest In Medpace 13
Partnerships 14
Actinium Pharma Enters into Agreement with Medpace 14
Medpace Enters into Amendment Agreement with Xenon Pharma 15
Medpace Enters into Agreement with Symplmed Pharmaceuticals 16
Equity Offering 17
Medpace Raises USD185.2 Million in IPO 17
Medpace Inc – Key Competitors 19
Medpace Inc – Key Employees 20
Medpace Inc – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Medpace Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Medpace Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medpace Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medpace Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medpace Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Medpace Inc, Medical Devices Deals, 2011 to YTD 2017 9
Medpace Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Cinven Acquires Medpace from CCMP Capital Advisors for USD915 Million 11
CCMP Capital Advisors Completes Acquisition Of 80% Interest In Medpace 13
Actinium Pharma Enters into Agreement with Medpace 14
Medpace Enters into Amendment Agreement with Xenon Pharma 15
Medpace Enters into Agreement with Symplmed Pharmaceuticals 16
Medpace Raises USD185.2 Million in IPO 17
Medpace Inc, Key Competitors 19
Medpace Inc, Key Employees 20
Medpace Inc, Other Locations 22
Medpace Inc, Subsidiaries 22

★海外企業調査レポート[Medpace Inc (MEDP)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China National Petroleum Corporation (CNPC):戦略・SWOT・企業財務分析
    China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Vallourec Sa
    Vallourec Sa - Strategy, SWOT and Corporate Finance Report Summary Vallourec Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Acasti Pharma Inc (ACST):製薬・医療:M&Aディール及び事業提携情報
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc, is a biopharmaceutical company that conducts research, development, and commercialization of krill oil-based forms of omega-3 fatty acids. The company develops phospholipid therapies for abnormalities in bl …
  • Kerr Corp:企業の戦略的SWOT分析
    Kerr Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • PT Perusahaan Gas Negara (Persero) Tbk (PGAS):企業の財務・戦略的SWOT分析
    PT Perusahaan Gas Negara (Persero) Tbk (PGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Analytica Limited (ALT):医療機器:M&Aディール及び事業提携情報
    Summary Analytica Limited (Analytica) is a specialty diagnostic and laboratory equipment company. It designs, develops and supplies Class I and II medical devices. The company provides women’s health systems and intravenous (IV) medication delivery systems. Its major products include PeriCoach e-hea …
  • JCB Co., Ltd.:企業の戦略・SWOT・財務情報
    JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JCB Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Verisante Technology Inc (VRS):製品パイプライン分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • The Scripps Research Institute-医療機器分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • Volkswind GmbH:企業の戦略的SWOT分析
    Volkswind GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Greenyard NV:企業の戦略・SWOT・財務分析
    Greenyard NV - Strategy, SWOT and Corporate Finance Report Summary Greenyard NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • ABB Ltd (ABBN)-エネルギー分野:企業M&A・提携分析
    Summary ABB Ltd. (ABB) is a provider of power and automation technologies. The company provides solutions for secure, energy-efficient generation, transmission and distribution of electricity and for increasing productivity in industrial, commercial and utility operations. ABB’s product and service …
  • TheraDiag SA (ALTER):医療機器:M&Aディール及び事業提携情報
    Summary Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels f …
  • Skanray Technologies Pvt Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Skanray Technologies Pvt Ltd (Skanray) is a medical equipment manufacturing company. It provides high frequency x-ray imaging systems, critical care devices, and primary healthcare and telemedicine compatible devices. The company’s product categories include defibrillator, ventilators, surgi …
  • Bilim Pharmaceuticals:企業の戦略的SWOT分析
    Bilim Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CardioFocus Inc:医療機器:M&Aディール及び事業提携情報
    Summary CardioFocus Inc (CardioFocus) is a medical device company that manufactures and distributes endoscopic ablation system for the treatment of cardiac disorders. The company offers heartlight endoscopic ablation system, which includes balloon catheter, endoscope, deflectable sheath, and integra …
  • Icon Genetics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Icon Genetics GmbH (Icon Genetics), a subsidiary of Denka Co Ltd, is a technology company that offers plant engineering technologies. The company develops, manufactures and markets biopharmaceutical product candidates, engineered organisms and technology platforms for plant biotechnology and …
  • Asure Software, Inc. (ASUR):企業の財務・戦略的SWOT分析
    Asure Software, Inc. (ASUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • RSWM Ltd. (RSWM):企業の財務・戦略的SWOT分析
    RSWM Ltd. (RSWM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆